(55 days)
A home ovulation predictor test. This kit provides a qualitative result for the detection of Luteinizing Hormone (LH) in urine.
Not Found
This document is a 510(k) clearance letter for an ovulation predictor kit, the OvuStick LH Test and OvuCard LH Test. It focuses on the regulatory clearance process and does not contain detailed information about acceptance criteria or specific study results as would be found in a clinical study report. Therefore, I cannot provide the requested information.
Here's why and what's missing:
- Acceptance Criteria and Device Performance: The document states that the device is "substantially equivalent" to legally marketed predicate devices. It does not provide specific performance metrics (e.g., sensitivity, specificity, accuracy) or the quantitative acceptance criteria linked to those metrics that were used to deem it equivalent.
- Study Details: There is no mention of a specific study to "prove the device meets acceptance criteria." The 510(k) process relies on demonstrating substantial equivalence, often through comparisons to existing devices and supporting data, but it doesn't typically require a standalone comprehensive study detailed in the clearance letter itself.
- Sample Sizes, Data Provenance, Ground Truth, Experts, MRMC/Standalone Studies, Training Set: All of these elements are related to a detailed clinical study, which is not described in this regulatory clearance letter.
In summary, this document is a regulatory approval letter and not a scientific study report.
§ 862.1485 Luteinizing hormone test system.
(a)
Identification. A luteinizing hormone test system is a device intended to measure luteinizing hormone in serum and urine. Luteinizing hormone measurements are used in the diagnosis and treatment of gonadal dysfunction.(b)
Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.